Learn More
Medchemexpress LLC MyoMed 205 | 2614161-13-4 | 99.31% | 491.56 | 100 MG

Supplier: Medchemexpress LLC HY164027100MG
MyoMed 205 is an inhibitor that targets the activity of MuRF1. It prevents early diaphragmatic systolic dysfunction and atrophy caused by unilateral diaphragmatic nerve denervation. This compound reduces ubiquitination and subsequent proteasomal degradation of muscle proteins by inhibiting MuRF1 activity. It also increases the levels of a protein that phosphorylates Akt (ser473), a crucial signaling molecule for muscle growth and maintenance. MyoMed 205 can be used for studying and treating diaphragmatic dysfunction and atrophy (DIDD).
- Targets the activity of MuRF1.
- Prevents early diaphragmatic systolic dysfunction and atrophy.
- Reduces ubiquitination and proteasomal degradation of muscle proteins.
- Increases levels of protein that phosphorylates Akt (ser473).
- Useful for studying and treating diaphragmatic dysfunction and atrophy (DIDD).
- For research use only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.